Filing search / Ownership / Cidara Therapeutics, Inc. / Page 3

8-K

9uary9v ze80

9 Feb 24

Other Events

8:00am

8-K

lkb5ewi7 1t0

22 Dec 23

Other Events

7:33am

8-K

9ov pqtt6p

17 Nov 23

Other Events

1:22pm

8-K

s0swbz025e 4sje5

16 Nov 23

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

4:05pm

8-K

ti1z8

2 Nov 23

Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results

4:08pm

8-K

jouw2j5luu2r9a fy

13 Oct 23

Cidara Therapeutics and Mundipharma receive positive CHMP opinion for rezafungin for the treatment of Invasive Candidiasis in adults1

10:36am

8-K

df4alqx v5s2xg

21 Sep 23

Other Events

1:24pm

8-K

2u7e1 ocbh0g7

6 Sep 23

Cidara Therapeutics Announces Janssen’s Election to Proceed Under its License Agreement Relating to Novel Drug-Fc Conjugates Targeting Influenza

8:05am

8-K

54rhfqb kn58j9

3 Aug 23

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results

4:03pm

UPLOAD

dwt59 emhfnktwb

24 Jul 23

Letter from SEC

12:00am

CORRESP

gvuec jcp

7 Jul 23

Correspondence with SEC

12:00am

UPLOAD

yvxcicyrws6ky1b1

26 Jun 23

Letter from SEC

12:00am

8-K

c28oyw0eb3

23 Jun 23

Submission of Matters to a Vote of Security Holders

4:07pm

CORRESP

i5i728ys xxkt2ack

31 May 23

Correspondence with SEC

12:00am

8-K

wfbunu

11 May 23

Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results

4:16pm

UPLOAD

20pf9

28 Apr 23

Letter from SEC

12:00am

ARS

nqakullrbx4

27 Apr 23

Annual report to shareholders

4:45pm